TrialBMC pharmacology & toxicology2019

First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers.

Lisa M Pitchford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.